v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ 1,564 $ (1,348)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Interest credited to policyholders’ account balances 2,397 2,272
Policy charges and fee income (1,343) (1,733)
Net derivative (gains) losses 1,455 1,692
Credit and intent to sell losses on available-for-sale debt securities and loans 101 43
Investment (gains) losses, net 77 1,212
Realized and unrealized (gains) losses on trading securities 54 (89)
Loss on novation 13 499
AB Retirement plan losses 0 18
Non-cash long term incentive compensation expense 85 64
Amortization and depreciation 617 652
Remeasurement of liability for future policy benefits 9 44
Change in market risk benefits (1,405) (287)
Equity (income) loss from limited partnerships (49) (142)
Changes in:    
Net broker-dealer and customer related receivables/payables (35) (204)
Reinsurance recoverable and related balances, net (1,027) (806)
Segregated securities 120 75
Capitalization of deferred policy acquisition costs (904) (857)
Future policy benefits (225) 4
Current and deferred income taxes (196) (753)
Other, net 1,466 512
Net cash provided by (used in) operating activities 2,774 868
Proceeds from the sale/maturity/pre-payment of:    
Fixed maturities, available-for-sale 10,510 14,228
Fixed maturities, at fair value using the fair value option 520 560
Mortgage loans on real estate 2,463 1,328
Trading account securities 370 370
Short term investments 22 137
Other 415 471
Payment for the purchase/origination of:    
Fixed maturities, available-for-sale (18,330) (20,108)
Fixed maturities, at fair value using the fair value option (936) (953)
Mortgage loans on real estate (4,447) (3,406)
Mortgage loans, at fair value using the fair value option (25) 0
Trading account securities (753) (757)
Short term investments (48) (106)
Other (409) (331)
Cash settlements related to derivative instruments, net 1,709 485
Investment in capitalized software, leasehold improvements and EDP equipment (35) (50)
Other, net (185) (353)
Net cash provided by (used in) investing activities (9,159) (8,485)
Policyholders’ account balances:    
Deposits 22,524 20,504
Withdrawals (15,173) (8,179)
Transfers (to) from Separate Accounts 1,446 1,425
Payments of market risk benefits (472) (516)
Repayment of short-term financings (25) 0
Change in collateralized pledged assets (496) 53
Change in collateralized pledged liabilities 4,348 3,482
Issuance of long-term debt 0 495
Repayment of long term debt 0 (500)
Proceeds from collateralized loan obligations 57 46
Repayment of collateralized loan obligations (46) (52)
Proceeds from notes issued by consolidated VIEs 1,528 1,260
Repayment of notes issued by consolidated VIEs (735) (842)
Dividends paid on common stock (241) (237)
Dividends paid on preferred stock (41) (48)
Redemption of preferred stock 0 439
Purchase of AllianceBernstein Units 0 (758)
Purchase of AB Holding Units to fund long-term incentive compensation plan awards, net (65) (48)
Purchase of treasury shares (751) (1,173)
Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds 112 147
Distribution to noncontrolling interest of consolidated subsidiaries (271) (306)
Change in securities lending (93) (60)
Other, net 48 (32)
Net cash provided by (used in) financing activities 11,654 14,222
Effect of exchange rate changes on cash, cash equivalents and segregated cash (4) 35
Change in cash, cash equivalents and segregated cash 5,265 6,640
Cash, cash equivalents and segregated cash, beginning of period 12,462 6,964
Cash, cash equivalents and segregated cash, end of period 17,727 13,604
Reconciliation of cash and cash equivalents, including amounts restricted:    
Cash and cash equivalents 17,527 [1] 13,604
Restricted cash included in cash and securities segregated, at fair value 200 0
Total cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flow 17,727 13,604
Non-cash transactions from investing and financing activities:    
Transfer of securities to reinsurer 0 8,777
Transfer of policy loans to reinsurer 0 2,533
Right-of-use assets obtained in exchange for lease obligations $ 35 $ 67
[1] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.